Article Details

ICER, unconvinced by Biogen data, suggests low price for Alzheimer's drug

Retrieved on: 2021-05-05 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

ICER, unconvinced by Biogen data, suggests low price for Alzheimer's drug. View article details on hiswai:

Excerpt

"This is an odd case because no one knows what the FDA is going to do here," he said. Recommended Reading: BioPharma Dive As review of its ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up